Concepedia

Shuji Momose

SM

Statistics

Publications

21

Citations

651

H-Index

15

Active since

2000

Affiliations

Social Insurance Saitama Chuo Hospital(Current)

Saitama Medical University

Juntendo University

The University of Tokyo

Jichi Medical University

Shuji Momose is an author at Social Insurance Saitama Chuo Hospital specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2000–2023

21

Publications

21

ARID2 is a pomalidomide-dependent CRL4CRBN substrate in multiple myeloma cells

Junichi Yamamoto, Tetsufumi Suwa, Yuki Murase et al. · Nature Chemical Biology · 2020 · 99 citations

, , +11

Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression

Michihide Tokuhira, Shuntaro Saito, Ayumi Okuyama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 61 citations

, , +14

LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells

Tomoyasu Jo, Momoko Nishikori, Yasunori Kogure et al. · Blood · 2020 · 54 citations · Full text

, , +14

Expression of Epstein-Barr Virus–Encoded Proteins in Extranodal NK/T-cell Lymphoma, Nasal Type (ENKL): Differences in Biologic and Clinical Behaviors of LMP1-Positive and -Negative ENKL

Naoko Kanemitsu, Yasushi Isobe, Azuchi Masuda et al. · Clinical Cancer Research · 2012 · 44 citations · Full text

, , +14

Hyperactivated STAT3 in ALK–positive diffuse large B-cell lymphoma with clathrin-ALK fusion

Shuji Momose, Jun‐ichi Tamaru, Hirohisa Kishi et al. · Human Pathology · 2008 · 39 citations

, , +8

1–5 of 21